Sector: HealthTech / Biotech
Platform: StartEngine
Valuation: $162.56 million
Minimum Investment: $990.90
🧩 What They Do
A pharmaceutical and medical device company known for its flagship formula, Hexagen Wound Dressing.
📈 Why It Might Be the Next Big Thing
FDA marketing approvals in advanced wound and dermatitis management
Demonstrates strong founder leadership
Positioned at the intersection of biotech and consumer health
💰 Who’s Backing Them
Notable Investors: ✅ GEM Global Yield LLC SCS ($75M public listing commitment)
📌 Snapshot
⭐ Notable Backers: ✅
💵 Min. Investment: $990.90
📊 Growth Signal: Product adoption in hospitals
🧠 Founder Cred: Self-tested biotech founder
🔎 My Take
Founder-led biotech with traction is a rare combo. High minimum investment, but high potential reward.
Explore Now
📖 Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice or investment solicitation.